Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia

Spine
Henrich ChengYang-Hsin Shih

Abstract

We present a case of a patient with chronic paraplegia with a complete spinal cord gap resulting from a stabbing injury 4 years ago recovering after an innovative surgical strategy. To demonstrate the clinical outcome of surgical repair with sural nerve graft with fibrin glue containing acidic fibroblast growth factor in a patient with chronic spinal cord injury. Spinal cord injury usually causes permanent disability, and there had been not effective surgical technique to obtain satisfactory functional motor recovery, particularly in chronic patients. Previous studies have revealed that acidic fibroblast growth factor could promote axonal regeneration and reduce neuronal death in adult rats with spinal cord injury. The spinal cord gap at T11 level was bridged with 4 sural nerve grafts that redirected specific pathways from white to gray matter. The grafted area was stabilized with fibrin glue containing acidic fibroblast growth factor. Before the operation, the paraplegia was identified as ASIA-C, with a motor score for the right and left legs of 12 and 0, respectively, a pinprick score of 77, and 77 on a light touch of left side limbs. His functional status improved from being wheelchair-bound to being able to ambulate indepen...Continue Reading

References

Jan 1, 1991·Experimental Brain Research·M M GiacobiniL Olson
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T Savio, M E Schwab
Apr 22, 1988·Neuroscience Letters·J W LittleR C Sohlberg
Mar 1, 1974·Brain : a Journal of Neurology·J R HeronB A Milner
Aug 1, 1996·Electroencephalography and Clinical Neurophysiology·B CalancieJ G Broton
May 18, 1999·Archives of Physical Medicine and Rehabilitation·J W LittleR M Harris
Feb 28, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·P CarigaP H Ellaway
Nov 13, 2002·Journal of Neurotrauma·Yu-Shang LeeVernon W Lin
Dec 21, 2002·Autonomic Neuroscience : Basic & Clinical·André ReitzBrigitte Schurch
Apr 10, 2003·Experimental Neurology·Ming-Chao HuangHenrich Cheng

❮ Previous
Next ❯

Citations

Feb 15, 2005·Magnetic Resonance Imaging·Federico GioveBruno Maraviglia
Feb 28, 2009·Nature Reviews. Drug Discovery·Andrew Beenken, Moosa Mohammadi
Mar 3, 2011·Journal of Neurotrauma·Samuel J MackenzieBlair Calancie
Jun 15, 2011·Journal of Neurosurgery. Spine·Michael G Fehlings, Jefferson R Wilson
Jun 15, 2011·Journal of Neurosurgery. Spine·Jau-Ching WuHenrich Cheng
Mar 4, 2008·Journal of Neurosurgery. Spine·Michael G Fehlings
Jan 3, 2006·Journal of Neurologic Physical Therapy : JNPT·Maria J Amador, James D Guest
Jan 25, 2007·Expert Opinion on Investigational Drugs·Martin Braddock
Jun 18, 2010·Brain Research Bulletin·George M Smith, Stephen M Onifer
Aug 12, 2009·Respiratory Physiology & Neurobiology·Xiao-Ming Xu, Stephen M Onifer
Oct 31, 2012·Annals of Neurology·Linard Filli, Martin E Schwab
Mar 20, 2015·Neural Regeneration Research·Wen-Tao ChenBao-Guo Jiang
Feb 14, 2015·Genes & Diseases·Chad M TevenRussell R Reid
Jan 22, 2013·World Neurosurgery·Basem I AwadMichael P Steinmetz
Oct 25, 2017·Journal of Cellular and Molecular Medicine·Yulong ZhouJian Xiao
Jul 22, 2006·Nature Reviews. Neuroscience·Sandrine ThuretFred H Gage
Jan 6, 2019·Journal of Neurosurgery. Spine·Jetan H BadhiwalaMichael G Fehlings
Apr 18, 2019·Therapeutic Delivery·Hyun Joon LeeParminder Js Vig
Jan 29, 2008·British Journal of Neurosurgery·S Knafo, D Choi
Jan 17, 2019·Current Drug Targets·Hassan Dianat-Moghadam, Ladan Teimoori-Toolabi
Jan 18, 2019·Neurospine·Chin-Chu KoHenrich Cheng
Feb 25, 2020·EMBO Molecular Medicine·Jarred M Griffin, Frank Bradke
Jan 3, 2006·Journal of Neurologic Physical Therapy : JNPT·Lawrence Moon, Mary Bartlett Bunge
May 13, 2018·Materials Science & Engineering. C, Materials for Biological Applications·Guodong SunBaocheng Wang
Aug 17, 2020·World Neurosurgery·Fabio TorregrossaGiovanni Grasso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.